EPS for AmpliPhi Biosciences Corporation (APHB) Expected At $-0.36

February 24, 2018 - By Marie Mckinney

 EPS for AmpliPhi Biosciences Corporation (APHB) Expected At $ 0.36

Analysts expect AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) to report $-0.36 EPS on March, 26.They anticipate $2.84 EPS change or 88.75 % from last quarter’s $-3.2 EPS. After having $-0.09 EPS previously, AmpliPhi Biosciences Corporation’s analysts see 300.00 % EPS growth. The stock increased 2.34% or $0.03 during the last trading session, reaching $1.31. About 92,322 shares traded. AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) has declined 94.86% since February 24, 2017 and is downtrending. It has underperformed by 111.56% the S&P500.

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage technology. The company has market cap of $12.44 million. It is also developing targeted and personalized bacteriophage therapies for patients with serious or life-threatening antibiotic-resistant infections. It currently has negative earnings. The firm has reported results from two Phase I clinical trials of AB-SA01 for the treatment of Staphylococcus aureus in chronic rhinosinusitis patients, as well as evaluating the safety of AB-SA01 when administered topically to the intact skin of healthy adults.

More notable recent AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) news were published by: Businesswire.com which released: “AmpliPhi Biosciences to Present at Biotech Showcase 2018” on January 02, 2018, also Seekingalpha.com with their article: “AmpliPhi Biosciences’ (APHB) CEO Paul Grint on Q2 2017 Results – Earnings Call …” published on August 15, 2017, Businesswire.com published: “AmpliPhi Biosciences Announces First Intravenous Treatment of a Patient with …” on September 11, 2017. More interesting news about AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) were released by: Marketwatch.com and their article: “Ampliphi Biosciences Corp.” published on May 05, 2017 as well as Businesswire.com‘s news article titled: “AmpliPhi Biosciences Provides Corporate and Strategic Update” with publication date: December 14, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: